Indicators of hemostasis and fibrinolysis systems in critically ill patients with COVID-19.

R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), Y. Berezovakiy (Moscow, Russian Federation), Y. Gretsov (Moscow, Russian Federation)

Source: Virtual Congress 2021 – COVID - 19 biomarkers
Session: COVID - 19 biomarkers
Session type: E-poster
Number: 645

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), Y. Berezovakiy (Moscow, Russian Federation), Y. Gretsov (Moscow, Russian Federation). Indicators of hemostasis and fibrinolysis systems in critically ill patients with COVID-19.. 645

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Indicators of systemic inflammation in critically ill patients with COVID-19.
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19.
Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Year: 2021


LATE-BREAKING ABSTRACT: The evolution of procalcitonin as a prognostic factor in critically ill patients with sepsis
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015

Which tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008


Why tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008


Antibiotics in the critically ill and septic patient
Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
Year: 2013

How can I prevent infectious complications in critically ill patients?
Source: Annual Congress 2008 - PG13 - Respiratory failure: skills needed to treat an episode of acute respiratory failure
Year: 2008



The practice of sedation in critically ill patients
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Steroid use in elderly critically ill COVID-19 patients
Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021
Year: 2021



Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016

Nutritional status and its impact on the outcome in critically ill COPD patients
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009


Body mass index and pulmonary complications in critically ill black patients
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016

Current practice in reducing perioperative and critical care pulmonary complications in obese patients: A review of London bariatric services
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016

Iloprost delivery and efficacy in critically ill patients
Source: Annual Congress 2007 - Problems in intensive care medicine
Year: 2007


Noninvasive ventilation during the weaning process in chronically critically ill patients
Source: ERJ Open Res, 2 (4) 00061-2016; 10.1183/23120541.00061-2016
Year: 2016



Resistin may predict severity and mortality in critically ill septic patients
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018